Previous Article | Next Article 
Journal of Virology, June 2001, p. 5043-5048, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5043-5048.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Incorporation of Lysyl-tRNA Synthetase into Human
Immunodeficiency Virus Type 1
Shan
Cen,1
Ahmad
Khorchid,1,2
Hassan
Javanbakht,1,2
Juliana
Gabor,1,3
Timothy
Stello,4
Kiyotaka
Shiba,5
Karin
Musier-Forsyth,4 and
Lawrence
Kleiman1,2,3,*
Lady Davis Institute for Medical Research and McGill AIDS
Centre, Jewish General Hospital,1 and
Departments of Medicine2 and
Microbiology & Immunology,3 McGill
University, Montreal, Quebec, Canada H3T 1E2; Department of
Cell Biology, Cancer Institute, Japanese Foundation for Cancer
Research, Kami-Ikebukuro, Toshima-ku, Tokyo 170, Japan5; and Department of Chemistry,
University of Minnesota, Minneapolis, Minnesota 554554
Received 21 December 2000/Accepted 3 March 2001
During human immunodeficiency virus type 1 (HIV-1) assembly,
tRNALys isoacceptors are selectively incorporated into
virions and tRNA
is used as the primer for reverse
transcription. We show herein that the tRNALys-binding
protein, lysyl-tRNA synthetase (LysRS), is also selectively packaged
into HIV-1. The viral precursor protein Pr55gag
alone will package LysRS into Pr55gag
particles, independently of tRNALys. With the additional
presence of the viral precursor protein Pr160gag-pol, tRNALys and LysRS are
both packaged into the particle. While the predominant cytoplasmic
LysRS has an apparent Mr of 70,000, viral LysRS
associated with tRNALys packaging is shorter, with an
apparent Mr of 63,000. The truncation occurs
independently of viral protease and might be required to facilitate
interactions involved in the selective packaging and genomic placement
of primer tRNA
.
*
Corresponding author. Mailing address: Lady Davis
Institute for Medical Research, Jewish General Hospital, 3755 Cote
Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2. Phone: (514)
340-8260. Fax: (514) 340-7502. E-mail:
lkleim{at}po-box.mcgill.ca.
Journal of Virology, June 2001, p. 5043-5048, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5043-5048.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wei, M., Yang, Y., Niu, M., Desfosse, L., Kennedy, R., Musier-Forsyth, K., Kleiman, L.
(2008). Inability of Human Immunodeficiency Virus Type 1 Produced in Murine Cells To Selectively Incorporate Primer Formula. J. Virol.
82: 12049-12059
[Abstract]
[Full Text]
-
Zhou, Y., Rong, L., Lu, J., Pan, Q., Liang, C.
(2008). Insulin-Like Growth Factor II mRNA Binding Protein 1 Associates with Gag Protein of Human Immunodeficiency Virus Type 1, and Its Overexpression Affects Virus Assembly. J. Virol.
82: 5683-5692
[Abstract]
[Full Text]
-
Kovaleski, B. J., Kennedy, R., Khorchid, A., Kleiman, L., Matsuo, H., Musier-Forsyth, K.
(2007). Critical Role of Helix 4 of HIV-1 Capsid C-terminal Domain in Interactions with Human Lysyl-tRNA Synthetase. J. Biol. Chem.
282: 32274-32279
[Abstract]
[Full Text]
-
Kaminska, M., Shalak, V., Francin, M., Mirande, M.
(2007). Viral Hijacking of Mitochondrial Lysyl-tRNA Synthetase. J. Virol.
81: 68-73
[Abstract]
[Full Text]
-
Kovaleski, B. J., Kennedy, R., Hong, M. K., Datta, S. A., Kleiman, L., Rein, A., Musier-Forsyth, K.
(2006). In Vitro Characterization of the Interaction between HIV-1 Gag and Human Lysyl-tRNA Synthetase. J. Biol. Chem.
281: 19449-19456
[Abstract]
[Full Text]
-
Guo, F., Gabor, J., Cen, S., Hu, K., Mouland, A. J., Kleiman, L.
(2005). Inhibition of Cellular HIV-1 Protease Activity by Lysyl-tRNA Synthetase. J. Biol. Chem.
280: 26018-26023
[Abstract]
[Full Text]
-
Kelly, N. J., Morrow, C. D.
(2005). Structural Elements of the tRNA T{Psi}C Loop Critical for Nucleocytoplasmic Transport Are Important for Human Immunodeficiency Virus Type 1 Primer Selection. J. Virol.
79: 6532-6539
[Abstract]
[Full Text]
-
Park, S. G., Kim, H. J., Min, Y. H., Choi, E.-C., Shin, Y. K., Park, B.-J., Lee, S. W., Kim, S.
(2005). From The Cover: Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc. Natl. Acad. Sci. USA
102: 6356-6361
[Abstract]
[Full Text]
-
Gurer, C., Hoglund, A., Hoglund, S., Luban, J.
(2005). ATP{gamma}S Disrupts Human Immunodeficiency Virus Type 1 Virion Core Integrity. J. Virol.
79: 5557-5567
[Abstract]
[Full Text]
-
Roldan, A., Warren, O. U., Russell, R. S., Liang, C., Wainberg, M. A.
(2005). A HIV-1 Minimal Gag Protein Is Superior to Nucleocapsid at in Vitro Annealing and Exhibits Multimerization-induced Inhibition of Reverse Transcription. J. Biol. Chem.
280: 17488-17496
[Abstract]
[Full Text]
-
Miller, J. T., Khvorova, A., Scaringe, S. A., Le Grice, S. F. J.
(2004). Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes. Nucleic Acids Res
32: 4687-4695
[Abstract]
[Full Text]
-
Halwani, R., Cen, S., Javanbakht, H., Saadatmand, J., Kim, S., Shiba, K., Kleiman, L.
(2004). Cellular Distribution of Lysyl-tRNA Synthetase and Its Interaction with Gag during Human Immunodeficiency Virus Type 1 Assembly. J. Virol.
78: 7553-7564
[Abstract]
[Full Text]
-
Cen, S., Javanbakht, H., Niu, M., Kleiman, L.
(2004). Ability of Wild-Type and Mutant Lysyl-tRNA Synthetase To Facilitate tRNALys Incorporation into Human Immunodeficiency Virus Type 1. J. Virol.
78: 1595-1601
[Abstract]
[Full Text]
-
Guo, F., Cen, S., Niu, M., Javanbakht, H., Kleiman, L.
(2003). Specific Inhibition of the Synthesis of Human Lysyl-tRNA Synthetase Results in Decreases in tRNALys Incorporation, tRNA3LysAnnealing to Viral RNA, and Viral Infectivity in Human Immunodeficiency Virus Type 1. J. Virol.
77: 9817-9822
[Abstract]
[Full Text]
-
Kelly, N. J., Palmer, M. T., Morrow, C. D.
(2003). Selection of Retroviral Reverse Transcription Primer Is Coordinated with tRNA Biogenesis. J. Virol.
77: 8695-8701
[Abstract]
[Full Text]
-
Dupuy, L. C., Kelly, N. J., Elgavish, T. E., Harvey, S. C., Morrow, C. D.
(2003). Probing the Importance of tRNA Anticodon: Human Immunodeficiency Virus Type 1 (HIV-1) RNA Genome Complementarity with an HIV-1 That Selects tRNAGlu for Replication. J. Virol.
77: 8756-8764
[Abstract]
[Full Text]
-
Javanbakht, H., Halwani, R., Cen, S., Saadatmand, J., Musier-Forsyth, K., Gottlinger, H., Kleiman, L.
(2003). The Interaction between HIV-1 Gag and Human Lysyl-tRNA Synthetase during Viral Assembly. J. Biol. Chem.
278: 27644-27651
[Abstract]
[Full Text]
-
Francin, M., Mirande, M.
(2003). Functional Dissection of the Eukaryotic-specific tRNA-interacting Factor of Lysyl-tRNA Synthetase. J. Biol. Chem.
278: 1472-1479
[Abstract]
[Full Text]
-
Cen, S., Javanbakht, H., Kim, S., Shiba, K., Craven, R., Rein, A., Ewalt, K., Schimmel, P., Musier-Forsyth, K., Kleiman, L.
(2002). Retrovirus-Specific Packaging of Aminoacyl-tRNA Synthetases with Cognate Primer tRNAs. J. Virol.
76: 13111-13115
[Abstract]
[Full Text]
-
Javanbakht, H., Cen, S., Musier-Forsyth, K., Kleiman, L.
(2002). Correlation Between tRNALys3 Aminoacylation and Its Incorporation into HIV-1. J. Biol. Chem.
277: 17389-17396
[Abstract]
[Full Text]
-
Kameoka, M., Morgan, M., Binette, M., Russell, R. S., Rong, L., Guo, X., Mouland, A., Kleiman, L., Liang, C., Wainberg, M. A.
(2002). The Tat Protein of Human Immunodeficiency Virus Type 1 (HIV-1) Can Promote Placement of tRNA Primer onto Viral RNA and Suppress Later DNA Polymerization in HIV-1 Reverse Transcription. J. Virol.
76: 3637-3645
[Abstract]
[Full Text]
-
Francin, M., Kaminska, M., Kerjan, P., Mirande, M.
(2002). The N-terminal Domain of Mammalian Lysyl-tRNA Synthetase Is a Functional tRNA-binding Domain. J. Biol. Chem.
277: 1762-1769
[Abstract]
[Full Text]